期刊
REVISTA ESPANOLA DE CARDIOLOGIA
卷 74, 期 12, 页码 1055-1062出版社
EDICIONES DOYMA S A
DOI: 10.1016/j.recesp.2020.09.002
关键词
Economic evaluation; Ischaemic heart disease; Acute coronary syndrome; Acute myocardial infarction; Multivessel disease; Revascularization; Percutaneous coronary intervention; Primary angioplasty
An economic evaluation of the CROSS-AMI trial showed that SelR may be more efficient than ComR in patients with ST-segment elevation acute coronary syndrome and multivessel disease, as the costs during follow-up were lower in the SelR group.
Introduction and objectives: Economic studies may help decision making in the management of multivessel disease in the setting of myocardial infarction. We sought to perform an economic evaluation of CROSS-AMI (Complete Revascularization or Stress Echocardiography in Patients With Multivessel Disease and ST-Segment Elevation Acute Myocardial Infarction) randomized clinical trial. Methods: We performed a cost minimization analysis for the strategies (complete angiographic revascularization [ComR] and selective stress echocardiography-guided revascularization [SelR]) compared in the CROSS-AMI clinical trial (N = 306), attributable the initial hospitalization and readmissions during the first year of follow-up, using current rates for health services provided by our health system. Results: The index hospitalization costs were higher in the ComR group than in SelR arm (19 657.9 +/- 6236.8 (sic) vs 14 038.7 +/- 4958.5 (sic) ; P < .001). There were no differences in the costs of the first year of follow-up rehospitalizations between both groups for (ComR 2423.5 +/- 4568.0 vs SelR 2653.9 +/- 5709.1; P = .697). Total cost was 22 081.3 +/- 7505.6 for the ComR arm and 16 692.6 +/- 7669.9 for the SelR group (P < .001). Conclusions: In the CROSS-AMI trial, the initial extra economic costs of the ComR versus SelR were not offset by significant savings during follow-up. SelR seems to be more efficient than ComR in patients with ST-segment elevation acute coronary syndrome and multivessel disease treated by emergent angioplasty. (C) 2020 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据